INTRODUCTION
In Japan, Shibaura strain has been used since 1965 as a stable virulent strain for preparing the vaccine and therapeutic antiserum for Weil's disease and as a challenge strain for assaying the products for the potencies (Moni et al., 1974) . The strain has also been used for various studies in many laboratories in this country.
Recently, Yanagawa and Adachi (1977) indicated that Shibaura strain which had been classified as a serovar icterohaemorrhagiae of serogroup Icterohaemorrhagiae was serovar copenhageni of the same serogroup. The result has been confirmed in this study. The fact raised a question as to whether Shibaura strain is suitable for preparing such biological products as vaccine and therapeutic antiserum for Weil's disease. It then urged us to clarify the antigenic relations between serovars icterohaemorrhagiae and copenhageni in respect to the protective antigenicity. Unfortunately, we had no other virulent strain than Shibaura(v), the challenge was made with virulent Shibaura(v) alone in this work.
MATERIALS AND METHODS
Strains: Shibaura strain was isolated from Rattus norvegicus by us in 1964 and has been kept by two different methods; Shibaura(v) by in vivo and Shibaura(av) by in vitro passage. For passage of Shibaura(v), a small amount of the liver emulsion of the moribund guinea pig infected with the pathogen was inoculated subcutaneously into healthy animals at intervals of 4 to 7 days. Sometimes a blood sample taken by heart puncture from the infected animal was also used as an inoculum. The same isolate has been passaged over 300 times in Korthof's medium from just after the isolation and the virulence has been lost. The resulting avirulent strain is called Shibaura(av). Other 14 strains of 13 serovars of leptospira maintained in this laboratory were also used (Table II) .
Antisera: Rabbit antisera were prepared by the following procedures. To prepare the antigen for immunizing rabbits, 200 ml of well-grown fresh culture of leptospira in Korthof's medium was centrifuged at 8,000 rpm for 30 min; the precipitate was resuspended in 4 ml of phosphate buffered saline, pH 7.3. The concentrated leptospiral suspension (about 1010 organisms) was injected twice subcutaneously and then 7 times intravenously at intervals of 4 or 5 days into two or more animals. The rabbits were bled 5 or 6 days after the last immunization (about 7 weeks after the first inoculation); the immune sera were stored at -20 C until use.
Microscopic agglutination test: The agglutinin titer of the immune serum was estimated by modified Schi ffner-Mochtar's microscopic agglutination method (Schi ffner and Mochtar, 1927) , in which the antiserum was diluted twofold serially with a microtitrating diluter. The reciprocal of the dilution of the antiserum showing about 50% agglutination was taken as the microscopic agglutinating antibody titer.
Determination o f the leptospiricidal activity o f the antisera: This was carried out by the procedures described by Akama et al. (1975) . Each of an adequate volume of the antiserum serially diluted at an interval of 0.25 in logarithm was mixed well with an equal volume of an adequate dilution of the leptospiral suspension. The leptospiral suspension was prepared according to the Minimum Requirement of Biological Products (Ministry of Health and Welfare, Japanese Government, 1973) . The liver of the moribund guinea pig with typical jaundice from infection with Shibaura(v) strain was emulsified with phosphate buffered saline of pH 7.3. The emulsion was centrifuged at 3,500 rpm for 30 min. The supernatant leptospiral suspension usually contained 106-107 organisms per ml. The mixtures of the serially diluted antiserum and the leptospiral suspension were incubated at 32 C for 30 min; 0.1-ml doses of each of them were injected intracutaneously into the backs of two or more guinea pigs weighing 450-500 g. Each animal usually received 10 to 20 injections of the series of a mixture. After seven days of the injection, the geometrical mean of the highest dilution of the antiserum preventing the development of local 
RESULTS
For serotyping Shibaura strain, the agglutinin absorption test was carried out with four strains, M20 of copenhageni, RGA of icterohaemorrhagiae, and the two substrains of Shibaura. As shown in Table I , Shibaura(v) shared an antigen with M20, while Shibaura(av) with RGA, though there were some discrepancies in both groups.
LCAs of the absorbed antisera are also shown in Table I . LCAs of the original antisera were completely lost after the absorption. No LCA was detected in the anti-copenhageni antiserum after absorption with the icterohaemorrhagiae antigen.
LCAs of antisera to various serovars together with their agglutinin titers are shown in Table II . The first six antisera to four serovars of serogroup Icterohaemorrhagiae (icterohaemorrhagiae, copenhageni, mankarso and naam) showed not only high agglutinin titers to Shibaura(v) but also obvious LCA, though LCAs of anti-mankarso and anti-naam antisera were rather low. Nine serovars belonging to other serogroups had no or little cross antigenicity with copenhageni or icterohaemorrhagiae; the antisera against them showed extremely low, if any, LCAs. Namely, the antisera to four serovars of three serogroups, canicola (serogroup Canicola), pyro genes and zanoni (Pyrogenes), and autumnalis (Autumnalis) were proved to have a little LCA when a low challenge dose was used, but the antiserum to I-201 strain of autumnalis had no LCA at all. No LCA was demonstrated in the antisera against five serovars, javanica (serogroup Javanica), cynoibteri (Cynopteri), grippotyphosa (Grippotyphosa), hebdomadis (Hebdomadis) and semaranga (Semaranga), belonging to other five serogroups.
To estimate LCA of the antisera against naam and mankarso of Icterohaemorrhagiae, a similar experiment was made with three strains, Naam (naam), Mankarso (mankarso) and Shibaura(v) (copenhageni). The results are shown in Table III . LCAs of the anti-Mankarso and anti-Naam antisera were much lower than that of the anti-Shibaura(v) antiserum. LCA of the anti-Shibaura(v) antiserum reduced little by absorption with Mankarso or Naam antigen, while those of anti-Mankarso and anti-Naam antisera reduced extremely by the absorption with any of the three antigens. isolation of the organisms by Inada et al, in 1915. However, Shibaura strain, which has widely been used for many practical purposes as serovar icterohaemorrhagiae, was confirmed to be serovar copenhageni by Yanagawa and Adachi (1977) and also by us in this study. Furthermore, the authors confirmed the additional finding by Yanagawa et al. that another strain, Hokota-6, was also rather copenhageni than icterohaemorrhagiae (unpublished data). That copenhageni was isolated in at least some regions in this country suggests that Weil's disease in Japan is caused by icterohaemorrhagiae as well as copenhageni, though there has been no report on isolation of copenhageni from any patient of Well's disease in this country. Borg-Petersen (1938) concluded that there are no differences in the clinical pictures between the patients caused by the two serovars. Serovar copenhageni will be detected in future in specimens from patients of the disease in Japan. This investigation was carried out mainly on the cross protective antigenicity between icterohaemorrhagiae and copenhageni for a practical purpose as mentioned above. Leptospiricidal activity of the antiserum seemed to be almost serogroup-specific, though LCAs of the antisera to mankarso and naam were considerably lower than those of copenhageni and icterohaemorrhagiae. LCAs of antisera to some serovars belonging to different serogroups were by far lower than those of the formers. A few studies have been carried out on the interserogroup or interserovar cross protection. Kemenes (1964) demonstrated interserovar postinfection immunities among many serovars though they were not so solid. Plesko and Lataste-Dorolle (1970) also revealed a high degree of mutual interserovar postinfection immunity in the animals surviving preliminary infection with a massive dose of a virulent heterologous serovar. The postinfection immunity did not prevent the infection by the second challenge with heterologous serovar, but protected the animals from deaths.
In our experiments, LCA of the antisera seemed to be related to their cross agglutination titers. Plesko and Lataste-Dorolle (1970) stated that the first infection caused formation of the agglutinating antibodies, and suggested that the cross agglutinating antibodies might play sometimes a certain role in cross immunity. The role of agglutinating antibodies in protection will be discussed in following papers. The serovar (serogroup in effect) specificity of the vaccine was excellently proved in a field vaccination trial using pyrogenes vaccine by our cooperative group in Okinawa Prefecture in 1977-1979 (to be published). The group confirmed that some patients in the field were infected with heterologous serovar a few years ago, and also that some other patients received two doses of the heterologous serovar vaccine a few months before.
It was evident that the antiserum to icterohaemorrhagiae protected perfectly the infection of copenhageni having an additional antigen, while the antibody to such additional antigen had no effect on the protection. Shibaura strain belonging to copenhageni has been used instead of icterohaemorrhagiae as the antigen for preparing the biological products without any suspicion. The results described here suggest the feasibility of preparing the biological products for Weil's disease with copenhageni as well as icterohaemorrhagiae antigens. It may also be possible to use a virulent strain of either serovar for the potency tests of the products. The WHO Expert Committee (1967) recommended that studies should be made to develop a widely effective polyvalent vaccine for preventing leptospirosis. The results shown here will certainly present important information for selecting the vaccine strain.
The authors presume that Shibaura strain was probably copenhageni when it was isolated and that Shibaura(v) has kept its original characters by repeating the in viva passage. It is not certain when and why the serovar of Shibaura strain varied from copenhageni to icterohaemorrhagiae during the in vitro passage. Recently, Yanagawa et al. (1974 , 1978 revealed that the change of serovar was induced in vitro as well as in viva in the presence of homologous antiserum. Shibaura(av) strain has never been cultured intentionally in any artificial medium containing anti-copenhageni antiserum. The change might have been caused by natural antibodies or something to inhibit selectively the growth of the virulent clone possibly contained in rabbit serum supplemented to Korthof's medium.
